6533b7d4fe1ef96bd1261e7b
RESEARCH PRODUCT
Development of antibiotic loaded biodegradable matrices to prevent superficial infections associated to total knee arthroplasty.
Javier Martínez-morenoJavier Martínez-morenoSilvia Mir-palomoMatilde Merino-sanjuánMatilde Merino-sanjuánAmparo NácherAmparo NácherVirginia MerinoVirginia Merinosubject
food.ingredientmedicine.drug_classCell SurvivalSurface PropertiesAntibioticsContext (language use)macromolecular substances02 engineering and technologyPharmacology01 natural sciencesGelatinChitosanchemistry.chemical_compoundMiceColloid and Surface ChemistryfoodOrganophosphorus CompoundsCiprofloxacin0103 physical sciencesmedicineAnimalsPhysical and Theoretical ChemistryParticle SizeCytotoxicityArthroplasty Replacement KneeCell ProliferationChitosan010304 chemical physicstechnology industry and agricultureSurfaces and InterfacesGeneral MedicineFibroblasts021001 nanoscience & nanotechnologyAnti-Bacterial Agentscarbohydrates (lipids)CiprofloxacinchemistrySelf-healing hydrogelsNIH 3T3 CellsGentamicinGentamicins0210 nano-technologyBiotechnologymedicine.drugdescription
Abstract Development of a pharmaceutical form for the superficial infections related with arthroplasties would be helpful for clinical practice. In this context, we set out to evaluate ciprofloxacin and gentamicin elution from systems based on chitosan. Films and semisolid hydrogels containing chitosan alone (2%) or in combination with gelatin (6%) or different proportions (from 12% to 36%) of tetrakis-(hydroxymethyl)-phosphonium-chloride (THPC) were tested as delivery systems. Different antibiotic doses were assayed (0.5 mg/cm2,1 mg/cm2 and 2 mg/cm2). Antibiotic release was studied for each formulation. In vitro cytocompatibility studies and a simulation exercise for bioactivity evaluation were performed. Samples containing chitosan or chitosan-gelatin released the antibiotics at very high rates. On the contrary, ciprofloxacin released was kept for 6 days from THPC-chitosan films and hydrogels. From hydrogel formulations release could be changed by varying the percentage of THPC. The system containing 12%-THPC-chitosan with 2 mg/cm2 of ciprofloxacin showed that 100% of patient would be covered during 72 h post-surgery. The concentration of 12%-THPC did not show cytotoxicity in NIH3T3 mouse fibroblasts after 48 h. THPC is suitable as crosslinker for chitosan when ciprofloxacin is incorporated showing a sustained release during 6 days.
year | journal | country | edition | language |
---|---|---|---|---|
2019-04-05 | Colloids and surfaces. B, Biointerfaces |